After analysis using the stratification method, prognostic significance of PHD3 was found in HCC patients with a single tumor, tumor size > 5 cm, HBV(+), AFP ≤ 20 μg/l, Edmondson stage I–II or BCLC stage 0+A. This evidence concerns the gene EGLN3 and hepatocellular carcinoma.